Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor - Wikidata - awgldk - TriplyDB

Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor

Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor

http://www.wikidata.org/entity/Q35025205

about

The tyrosine kinase c-Src enhances RIG-I (retinoic acid-inducible gene I)-elicited antiviral signaling Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance Dietary advanced glycation end products and their role in health and disease Role of advanced glycation end products in cellular signaling 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications The effect of an AGE-rich dietary extract on the activation of NF-κB depends on the cell model used.Prognostic potential and tumor growth-inhibiting effect of plasma advanced glycation end products in non-small cell lung carcinoma.Dangers within: DAMP responses to damage and cell death in kidney disease.Epidermal growth factor receptor is a preferred target for treating amyloid-β-induced memory loss.Huang Gan Formula Eliminates the Oxidative Stress Effects of Advanced Oxidation Protein Products on the Divergent Regulation of the Expression of AGEs Receptors via the JAK2/STAT3 Pathway.AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease.The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus.Glycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatment Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy.Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1 Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes.Reduced oxidant stress and extended lifespan in mice exposed to a low glycotoxin diet: association with increased AGER1 expression.Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial.Oral glycotoxins determine the effects of calorie restriction on oxidant stress, age-related diseases, and lifespan.AGE restriction in diabetes mellitus: a paradigm shift.RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db/db mice.Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the antiinflammatory AGE receptor-1.Advanced glycation end products (AGE) and diabetes: cause, effect, or both?Metabolism addiction in pancreatic cancer.Lipid glycation and protein glycation in diabetes and atherosclerosis.Cell signaling and receptors in toxicity of advanced glycation end products (AGEs): α-dicarbonyls, radicals, oxidative stress and antioxidants.Skin fibroblasts as a tool for identifying the risk of nephropathy in the type 1 diabetic population.Autophagy in pancreatic cancer.Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients.Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology.Molecular biology of atherosclerosis.Have we reached the limits for the treatment of diabetic nephropathy?

P2860

476c4272def6a337f34e2835855f5d9a91952ad0 c4b3257ff554947f0e65af4a6eb74d574d50a29b d0e53f757b985457a2b2cf33ba15d90df36510c6

P248

Q24322642-9F551636-5CB4-4B3F-8711-A3EF1289AFC9 Q26800114-304F010F-FD7D-4C78-866B-8A73C2F63B32 Q26801247-88C4F91E-3401-4F91-8467-D62B1151525C Q27003423-E333A8F3-1B78-40D2-A9EE-5324C6564175 Q30239808-31F0DA60-CA53-480F-9570-981589919B11 Q30317876-36563B0F-6C8B-4172-B430-23021F22406F Q30318385-8B1D00B6-C38A-4EC9-905B-B0C71424C54C Q30380000-E6EAA7BF-F655-43FA-AD9B-B0D4FA179093 Q30420041-0990FF59-F7BC-4C9C-9B34-FBA4E0E47DCA Q33561493-AB5C919E-35E1-4591-B43C-AC8E06845417 Q33727690-003726F1-D5B5-4CBD-8339-17381964D022 Q33851482-C9B746CF-0567-4E47-864F-7808A5A2EA6A Q33999815-9E77A941-9297-4A39-96AF-A965195F56DC Q34517974-FFD04648-4125-4843-83EE-E2BBFF2B36DB Q34557348-32023E45-42B3-4C1A-AD34-3E5D12C2E62A Q35060239-AC83BA48-A0BF-473C-BAA1-610E350033B1 Q35093747-175CE6B7-437D-4C2E-B2C1-7F82656A13D3 Q35170154-D6363C8F-4A73-40E4-BC5F-EE3F166311EC Q35830289-2AD80D7F-5F6E-4B82-A560-88F17ACFE732 Q35855642-602FE0CA-C885-45E7-A91B-1283D527390A Q35995060-A0517350-6159-4896-B0CB-B4AC0A166629 Q36080001-47AA5445-32D5-4EDC-ACD6-DA014A93F095 Q36300685-E674098C-D28F-4F51-8B22-FACBE1BC158A Q36571129-337A6BB5-DF69-4649-8CF3-82BD57401B64 Q36778201-AB7C86DB-59FF-486B-AA70-3ABC272E5F42 Q37003623-579F4BCB-CF76-4117-8F40-DF84A57F3335 Q37146417-5CB49670-FD07-4EAD-953B-0E8306AD5882 Q37362121-C1AB5EDD-9FCC-4268-91BA-5D92CB37B176 Q37379205-B6F082A5-1B6D-44FC-8735-626E72353477 Q37417494-2E06B27C-766B-4F8E-B310-1839450D3581 Q37520014-7B431007-FB56-4F73-B61D-24281EC79A56 Q37620679-C82F8272-2161-43C2-98B7-C56366732841 Q37801315-628C6CFA-A764-4218-A364-4044778B57A0 Q37934954-C6218360-E5D4-4144-B76E-8F67EF30BD26 Q37973267-DF762B4E-764E-441C-8701-73AC924651D5 Q37980135-46C5ED56-8400-498B-9B0F-C71CA557C32A Q38006722-309BD7C9-AE97-42B8-B23B-C757D19FFCC8 Q38108373-7E631336-4289-4F24-BFEE-B7C8B14BADB4 Q38125279-4680BA92-0D04-4CD6-9174-4C2F6A2462A0 Q38189884-62DC6787-4B27-4A8A-B3EC-297D5B530D71

P2860

Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor

http://www.wikidata.org/entity/Q35025205

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Advanced glycation end product ...... ion signaling via EGF receptor

@ast

Advanced glycation end product ...... ion signaling via EGF receptor

@en

type

label

Advanced glycation end product ...... ion signaling via EGF receptor

@ast

Advanced glycation end product ...... ion signaling via EGF receptor

@en

prefLabel

Advanced glycation end product ...... ion signaling via EGF receptor

@ast

Advanced glycation end product ...... ion signaling via EGF receptor

@en

P1433

Q35025205-228A0E56-728D-445E-8592-947AF397EDB9

P1476

Q35025205-E9D986AF-8A93-4681-AD80-427183833D96

P2093

Q35025205-684772BD-8B9E-40DB-8D10-D2571E2392DE

Q35025205-6F348FB0-41FD-4830-ABF7-CC3524946B0B

Q35025205-97B98B30-AEC6-4579-BE2C-DC15747B5DBE

Q35025205-C2F7DAD5-4B1B-4AE9-A34A-B384BBFFC1FF

Q35025205-F9EB0AF4-B252-4EB8-8FA4-FCDAB5ADAD1D

P2860

Q35025205-009E8B4D-137E-4BC0-848F-7D0366E4CEF0

Q35025205-0314A9E9-DEC3-4D57-B658-BAB9051183B2

Q35025205-08A0F5B4-18E0-4887-8F77-9AF05DFED1DC

Q35025205-1A01841F-DDE9-470C-83C4-99D1DA672ECE

Q35025205-20F8212E-B45D-43D9-9514-9A22343E7092

Q35025205-2553D03B-0DFA-4589-AA11-80F347F1BC9D

Q35025205-256F2941-4220-42E9-95D6-248EF6EF3390

Q35025205-29D970B8-ED07-443D-AEB4-ACCE4B8F954F

Q35025205-2ACE1E56-6CE0-4E34-BD0E-6D661EA22CA3

Q35025205-2E4463FD-97A3-4F6A-AA78-E6A3D6856FF4

P304

Q35025205-6136858F-2401-4D20-B6A8-F776B37BE82A

P31

Q35025205-FC37E88B-F134-414C-BEBC-C93E9CCE48A3

P356

Q35025205-A98F228E-E179-40E9-81D2-356C90861DA1

P407

Q35025205-C7FFB1AB-EAA4-4042-905B-F1D0CF4DEF29

P433

Q35025205-62D5CFAF-23D1-4D01-8462-C2499231F907

P478

Q35025205-BE91B87B-8171-4D85-9364-7314C16BC295

P577

Q35025205-37A81443-9C2B-4A33-B489-5D02DBA11D35

P5875

Q35025205-87C94DE0-79ED-44E5-95BD-707E353F5B4C

P698

Q35025205-D41538F7-B8BF-4EF1-A653-4C55E5F450E8

P921

Q35025205-7BAB37F7-4696-4E80-B17F-1AA74438BC5A

P932

Q35025205-D514899F-5674-4AD5-B8C2-41430A39277C

P356

PNAS.0600362103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Advanced glycation end product ...... ion signaling via EGF receptor

@en

P2093

Changyong Lu

http://www.w3.org/2001/XMLSchema#string

Helen Vlassara

http://www.w3.org/2001/XMLSchema#string

John C He

http://www.w3.org/2001/XMLSchema#string

Li Zhu

http://www.w3.org/2001/XMLSchema#string

Weijing Cai

http://www.w3.org/2001/XMLSchema#string

P2860

Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells

Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells

Oxidants, oxidative stress and the biology of ageing

Signaling via Shc family adapter proteins

Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

Requirement for generation of H2O2 for platelet-derived growth factor signal transduction

Epidermal growth factor receptors: critical mediators of multiple receptor pathways.

The epidermal growth factor.

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.

P304

13801-13806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0600362103

http://www.w3.org/2001/XMLSchema#string

P407

P433

37

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6836293

http://www.w3.org/2001/XMLSchema#string

P698

16954185

http://www.w3.org/2001/XMLSchema#string

P921

Epidermal growth factor receptor

P932

1564251

http://www.w3.org/2001/XMLSchema#string